Jeffrey D Long

Summary

Affiliation: University of Iowa
Country: USA

Publications

  1. pmc 8OHdG as a marker for Huntington disease progression
    Jeffrey D Long
    Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    Neurobiol Dis 46:625-34. 2012
  2. pmc Cognitive decline in prodromal Huntington Disease: implications for clinical trials
    Jane S Paulsen
    Department of Neurology, Carver College of Medicine, Univeristy of Iowa, Iowa City, Iowa, USA
    J Neurol Neurosurg Psychiatry 84:1233-9. 2013
  3. pmc Measuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington disease
    Kathryn V Papp
    Department of Psychiatry, Harvard Medical School, Boston, MA 02215, USA
    Arch Clin Neuropsychol 28:156-68. 2013
  4. ncbi request reprint WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease
    Nancy R Downing
    College of Nursing, University of Iowa, Iowa City, IA, USA
    Eur J Hum Genet 22:958-63. 2014
  5. pmc Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study
    Eric A Epping
    Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA 52242 1000, USA
    J Psychiatr Res 47:1423-31. 2013
  6. pmc Diffusion weighted imaging of prefrontal cortex in prodromal Huntington's disease
    Joy T Matsui
    Department of Psychiatry, The University of Iowa, Iowa City, Iowa John A Burns School of Medicine, The University of Hawaii, Honolulu, Hawaii
    Hum Brain Mapp 35:1562-73. 2014
  7. pmc Indexing disease progression at study entry with individuals at-risk for Huntington disease
    Ying Zhang
    Department of Biostatistics, University of Iowa, Iowa City, USA
    Am J Med Genet B Neuropsychiatr Genet 156:751-63. 2011

Collaborators

  • Jatin G Vaidya
  • Ying Zhang
  • Peter J Snyder
  • Kevin Duff
  • Megan M Smith
  • Jane S Paulsen
  • James A Mills
  • Nancy R Downing
  • Joy T Matsui
  • Janet K Williams
  • Kathryn V Papp
  • Eric A Epping
  • Vincent A Magnotta
  • Stephen M Rao
  • Hans J Johnson
  • Ji In Kim
  • Mark J Lowe
  • Ken E Sakaie
  • Mark Groves
  • Jess G Fiedorowicz
  • Spencer Lourens
  • David Craufurd
  • Leigh J Beglinger
  • Nancy Downing
  • Holly J Westervelt
  • Kelly R Bijanki

Detail Information

Publications7

  1. pmc 8OHdG as a marker for Huntington disease progression
    Jeffrey D Long
    Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    Neurobiol Dis 46:625-34. 2012
    ..The finding that 8OHdG concentrations increased as a function of proximity to projected disease diagnosis and duration indicates support for the continued assessment of 8OHdG as a robust clinical HD biomarker...
  2. pmc Cognitive decline in prodromal Huntington Disease: implications for clinical trials
    Jane S Paulsen
    Department of Neurology, Carver College of Medicine, Univeristy of Iowa, Iowa City, Iowa, USA
    J Neurol Neurosurg Psychiatry 84:1233-9. 2013
    ..Many longitudinal studies of cognitive decline in prodromal HD have not stratified samples based on disease progression, thereby obscuring differences between symptomatic and nonsymptomatic individuals...
  3. pmc Measuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington disease
    Kathryn V Papp
    Department of Psychiatry, Harvard Medical School, Boston, MA 02215, USA
    Arch Clin Neuropsychol 28:156-68. 2013
    ....
  4. ncbi request reprint WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease
    Nancy R Downing
    College of Nursing, University of Iowa, Iowa City, IA, USA
    Eur J Hum Genet 22:958-63. 2014
    ..Results suggest the WHODAS can identify baseline and longitudinal differences in prodromal HD and may be useful in HD clinical trials. Companions may provide more accurate data as the disease progresses. ..
  5. pmc Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study
    Eric A Epping
    Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA 52242 1000, USA
    J Psychiatr Res 47:1423-31. 2013
    ..The clinical presentation appears to be similar to other populations. Severity and progression are not related to the HD mutation. ..
  6. pmc Diffusion weighted imaging of prefrontal cortex in prodromal Huntington's disease
    Joy T Matsui
    Department of Psychiatry, The University of Iowa, Iowa City, Iowa John A Burns School of Medicine, The University of Hawaii, Honolulu, Hawaii
    Hum Brain Mapp 35:1562-73. 2014
    ..The gradient of effects that tracked with CAP group suggests DWI may provide markers of disease progression in future longitudinal studies as increasing diffusivity abnormalities in the lateral PFC of prodromal HD individuals...
  7. pmc Indexing disease progression at study entry with individuals at-risk for Huntington disease
    Ying Zhang
    Department of Biostatistics, University of Iowa, Iowa City, USA
    Am J Med Genet B Neuropsychiatr Genet 156:751-63. 2011
    ..The classification is an improvement over the one currently in use as it is based on observed data rather than model-based estimated values. © 2011 Wiley-Liss, Inc...